Cyient has received a slew of downgrades post its results. JPMorgan has cut its price target on the stock to ₹1,750 from ₹2,300 earlier and has also cut its ratings to “neutral” from “overweight” earlier.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.